Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
‘She’s my inspiration’: Soon-to-be 100-year-old still woman walks over three miles a day at The Centre of Elgin
Soon-to-be 100-year-old Betty McKeown was celebrated during a party at The Centre of Elgin on Thursday.... -
Buffalo Grove DePaul student speaks out about antisemitic campus attack
A Stevenson High School graduate and DePaul University student spoke out about a campus antisemitic attack. -
Buffalo Grove DePaul student speaks out about antisemitic campus attack
A Stevenson High School graduate and DePaul University student spoke out about a campus antisemitic attack.